Antje Havemeyer

1.1k total citations
26 papers, 880 citations indexed

About

Antje Havemeyer is a scholar working on Molecular Biology, Biochemistry and Clinical Biochemistry. According to data from OpenAlex, Antje Havemeyer has authored 26 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Biochemistry and 8 papers in Clinical Biochemistry. Recurrent topics in Antje Havemeyer's work include Amino Acid Enzymes and Metabolism (8 papers), Metabolism and Genetic Disorders (8 papers) and Metalloenzymes and iron-sulfur proteins (8 papers). Antje Havemeyer is often cited by papers focused on Amino Acid Enzymes and Metabolism (8 papers), Metabolism and Genetic Disorders (8 papers) and Metalloenzymes and iron-sulfur proteins (8 papers). Antje Havemeyer collaborates with scholars based in Germany, Poland and Australia. Antje Havemeyer's co-authors include Bernd Clement, Florian Bittner, Ralf R. Mendel, Thomas Kunze, Gudrun Ott, Debora Reichmann, Bettina Wahl, Birte Plitzko, Dieter Garbe‐Schönberg and Juliane Lang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Antje Havemeyer

26 papers receiving 873 citations

Peers

Antje Havemeyer
Eugene G. Mueller United States
Daniel W. Bak United States
Thomas Kunze Germany
Su‐Shu Pan United States
June E. Ayling United States
Tsehai A.J. Grell United States
Jian Qiu China
Eugene G. Mueller United States
Antje Havemeyer
Citations per year, relative to Antje Havemeyer Antje Havemeyer (= 1×) peers Eugene G. Mueller

Countries citing papers authored by Antje Havemeyer

Since Specialization
Citations

This map shows the geographic impact of Antje Havemeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Havemeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Havemeyer more than expected).

Fields of papers citing papers by Antje Havemeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Havemeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Havemeyer. The network helps show where Antje Havemeyer may publish in the future.

Co-authorship network of co-authors of Antje Havemeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Havemeyer. A scholar is included among the top collaborators of Antje Havemeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Havemeyer. Antje Havemeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Havemeyer, Antje, et al.. (2019). Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in N-reductive activity and energy metabolism. Journal of Biological Chemistry. 294(46). 17593–17602. 17 indexed citations
2.
Bittner, Florian, et al.. (2018). Crystal structure of human mARC1 reveals its exceptional position among eukaryotic molybdenum enzymes. Proceedings of the National Academy of Sciences. 115(47). 11958–11963. 41 indexed citations
3.
Bittner, Florian, et al.. (2018). T4 lysozyme-facilitated crystallization of the human molybdenum cofactor-dependent enzyme mARC. Acta Crystallographica Section F Structural Biology Communications. 74(6). 337–344. 4 indexed citations
4.
Plitzko, Birte, Diana A. Stolfa, Manfred Jung, et al.. (2018). The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids. Drug Metabolism and Disposition. 46(10). 1396–1402. 18 indexed citations
5.
Kalimuthu, Palraj, et al.. (2017). Human mitochondrial amidoxime reducing component (mARC): An electrochemical method for identifying new substrates and inhibitors. Electrochemistry Communications. 84. 90–93. 11 indexed citations
6.
Plitzko, Birte, et al.. (2016). Defining the Role of the NADH–Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System. Drug Metabolism and Disposition. 44(10). 1617–1621. 10 indexed citations
7.
Plitzko, Birte, Antje Havemeyer, Thomas Kunze, & Bernd Clement. (2015). The Pivotal Role of the Mitochondrial Amidoxime Reducing Component 2 in Protecting Human Cells against Apoptotic Effects of the Base Analog N6-Hydroxylaminopurine. Journal of Biological Chemistry. 290(16). 10126–10135. 21 indexed citations
9.
Ott, Gudrun, Debora Reichmann, Ingolf Cascorbi, et al.. (2014). Functional Characterization of Protein Variants Encoded by Nonsynonymous Single Nucleotide Polymorphisms in MARC1 and MARC2 in Healthy Caucasians. Drug Metabolism and Disposition. 42(4). 718–725. 13 indexed citations
10.
Reichmann, Debora, Florian Bittner, Philipp Kurz, et al.. (2014). Electrochemical and mARC‐Catalyzed Enzymatic Reduction of para‐Substituted Benzamidoximes: Consequences for the Prodrug Concept “Amidoximes instead of Amidines”. ChemMedChem. 10(2). 360–367. 11 indexed citations
11.
Ott, Gudrun, Antje Havemeyer, & Bernd Clement. (2014). The mammalian molybdenum enzymes of mARC. JBIC Journal of Biological Inorganic Chemistry. 20(2). 265–275. 57 indexed citations
12.
Plitzko, Birte, Gudrun Ott, Debora Reichmann, et al.. (2013). The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b5 in N-Reductive Metabolism in Human Cells. Journal of Biological Chemistry. 288(28). 20228–20237. 43 indexed citations
13.
Clement, Bernd, Florian Bittner, Ralf R. Mendel, et al.. (2013). Activation of the anti-cancer agent upamostat by the mARC enzyme system. Xenobiotica. 43(9). 780–784. 28 indexed citations
14.
Havemeyer, Antje, et al.. (2012). Dimethylarginine‐Dimethylaminohydrolase‐2 (DDAH‐2) Does Not Metabolize Methylarginines. ChemBioChem. 13(17). 2599–2604. 11 indexed citations
15.
Havemeyer, Antje, Juliane Lang, & Bernd Clement. (2011). The fourth mammalian molybdenum enzyme mARC: current state of research. Drug Metabolism Reviews. 43(4). 524–539. 46 indexed citations
16.
Wahl, Bettina, Debora Reichmann, Dimitri Niks, et al.. (2010). Biochemical and Spectroscopic Characterization of the Human Mitochondrial Amidoxime Reducing Components hmARC-1 and hmARC-2 Suggests the Existence of a New Molybdenum Enzyme Family in Eukaryotes. Journal of Biological Chemistry. 285(48). 37847–37859. 96 indexed citations
17.
Havemeyer, Antje, Bettina Wahl, Florian Bittner, et al.. (2010). Reduction of N-Hydroxy-sulfonamides, Including N-Hydroxy-valdecoxib, by the Molybdenum-Containing Enzyme mARC. Drug Metabolism and Disposition. 38(11). 1917–1921. 37 indexed citations
18.
Havemeyer, Antje, et al.. (2006). Identification of the Missing Component in the Mitochondrial Benzamidoxime Prodrug-converting System as a Novel Molybdenum Enzyme. Journal of Biological Chemistry. 281(46). 34796–34802. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026